Title:
COMPOUNDS AS BCL-2 INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2024/032776
Kind Code:
A1
Abstract:
Provided are certain BCL-2 inhibitors, pharmaceutical compositions thereof, and methods of use thereof.
Inventors:
ZHOU CHENGLIN (CN)
ZHAO XINGDONG (CN)
WANG WEIBO (US)
ZHAO XINGDONG (CN)
WANG WEIBO (US)
Application Number:
PCT/CN2023/112601
Publication Date:
February 15, 2024
Filing Date:
August 11, 2023
Export Citation:
Assignee:
FOCHON BIOSCIENCES LTD (CN)
International Classes:
C07D471/04; A61K31/4353; A61K31/538; A61P35/00; A61P37/00; C07D498/04; C07D498/14; C07D498/22
Domestic Patent References:
WO2021066873A1 | 2021-04-08 | |||
WO2020041406A1 | 2020-02-27 | |||
WO2021223736A1 | 2021-11-11 | |||
WO2020140005A2 | 2020-07-02 | |||
WO2022149617A1 | 2022-07-14 | |||
WO2020088442A1 | 2020-05-07 |
Foreign References:
CN110546151A | 2019-12-06 | |||
CN114835704A | 2022-08-02 | |||
CN110177788A | 2019-08-27 | |||
CN102307872A | 2012-01-04 | |||
CN102947283A | 2013-02-27 | |||
CN108658983A | 2018-10-16 |
Attorney, Agent or Firm:
NTD UNIVATION INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF:
Previous Patent: QUANTIZATION METHOD AND APPARATUS
Next Patent: ANTI-CD73 ANTIBODY OR ANTIGEN FRAGMENT THEREOF AND USE THEREOF
Next Patent: ANTI-CD73 ANTIBODY OR ANTIGEN FRAGMENT THEREOF AND USE THEREOF